Is chocolate a psychotropic drug? - The role of β-phenylethalymine as psychostimulus;Ist schokolade ein psychopharmakon? - Die rolle von β-phenylethylamin als psychostimulus

Psychopharmakotherapie

Volumn 16, Issue 1, 2009, Pages 26-31

  Riederer, Peter F ^a   Burger, Rainer ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DEHYDROGENASE; AMINE; AMINO ACID; AMPHETAMINE; BENZENE DERIVATIVE; BETA PHENYLETHALYMINE; BIOGENIC AMINE; CARBOXYLYASE; DOPA; HISTIDINE; NEUROTRANSMITTER; PHENETHYLAMINE; PHENYLALANINE; PSYCHOSTIMULANT AGENT; PSYCHOTROPIC AGENT; TYROSINE; UNCLASSIFIED DRUG;

ARTICLE; BLOOD BRAIN BARRIER; CACAO; DRUG STRUCTURE; FOOD INTAKE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN;

EID: 60749095721     PISSN: 09446877     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Antelman SM, Edwards DJ, Lin M. Phenylethylamine: evidence for a direct, postsynaptic dopamine-receptor stimulating action. Brain Res 1977;127:317-22.
2. Axelrod J, Saavedra J. Octopamine, phenylethanolamine, phenylethylamine and tryptamine in the brain. In: Ciba Foundation Symposium 22 (new series) (eds.). Aromatic Amino Acids in the Brain. Amsterdam, London, New York: Elsevier, 1974:51-66.
3. Beckmann H, Strauss MA, Ludolph E. DL-Phenylalanine in depressed patients: an open study. J Neural Transm 1977;41:123-34.
4. Beckmann H, Reynolds GP, Sandler M, Waldmeier P, et al. Phenylethylamine and phenylacetic acid in CSF of schizophrenics and healthy controls. Arch Psychiatr Nervenkr 1982;232:463-71.
5. Bergman J, Yasar S, Winger G. Psychomotor stimulant effects of beta-phenylethylamine in monkeys treated with MAO-B inhibitors. Psychopharmacology (Berl) 2001;159:21-30.
6. Birkmayer W. Experimentelle Befunde und neue Aspekte bei extrapyramidalen Erkrankungen. Z Nervenheilkunde (Wien) 1966;13:128-39.
7. Birkmayer W, Neumayer E, Stöckl W, Weiler G. Defizit essentieller Aminosäuren bei endogener Depression. Wien Klin Wochenschr 1968;80:832-4.
8. Birkmayer W, Riederer P. Die Parkinson-Krankheit. Biochemie, Klinik, Therapie, Wien, New York: Springer Verlag, 1980.
9. Birkmayer W, Riederer P, Linauer W, Knoll J. L-Deprenyl plus L-Phenylalanine in the treatment of depression. J Neural Transm 1984;59:81-7.
10. Borison RI, Hafdala HS, Diamond BI. Chronic phenylethylamine stereotypy in rats: a new animal model for schizophrenia. Life Sci 1977;21:117-22.
11. Borowsky B, Adham N, Jones KA, Raddatz R, et al. Trace amines: identification of a family of mammalian G protein-coupled receptors. Proc Natl Acad Sci U S A 2001;98:8966-71.
12. Bunzow JR, Sonders MS, Arttamangkul S, Harrison LM, et al. Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor. Mol Pharmacol 2001;60:1181-8.
13. Coppen A. The biochemistry of affective disorders. Br J Psychiatry 1967;113:1237.
14. Federici M, Geracitano R, Tozzi A, Longone P, et al. Trace amines depress GABA B response in dopaminergic neurons by inhibiting G-betagamma-gated inwardly rectifying potassium channels. Mol Pharmacol 2005;67:1283-90.
15. Fernstrom JD, Madras BK, Munro HN, Wurtman RJ. Nutritional control of the synthesis of 5-hydroxytryptamine in the brain. In: Ciba Foundation Symposium 22 (new series) (eds.). Aromatic Amino Acids in the Brain. Amsterdam, London, New York: Elsevier, 1974:153-73.
16. Fischer E, Spatz H, Heller B, Reggiani H. Phenylethylamine content of human urine and rat brain, its alteration in pathological conditions and after drug administration. Experientia 1972;28:307.
17. Fischer E, Heller B, Nachon M, Spatz H. Therapy of depression by phenylalanine. Arzneimittelforschung (Drug Res) 1975;25:132.
18. Fisher ND, Hollenberg NK. Aging and vascular responses to flavanol-rich cocoa. J Hypertens 2006;24:1575-80.
19. Fisher ND, Sorond FA, Hollenberg NK. Cocoa flavanols and brain perfusion. J Cardiovasc Pharmacol 2006;47(Suppl 2):S210-4.
20. Fuxe K, Grobecker H, Jonsson G. The effect of β-phenethylamine on central and peripheral monoamine containing neurons. Eur J Pharmacol 1967;2:200-7.
21. Geracitano R, Federici M, Prisco S, Bernardi G, et al. Inhibitory effects of trace amines on rat midbrain dopaminergic neurons. Neuropharmacology 2004;46:807-14.
22. Gutknecht L, Waider J, Kraft S, Kriegebaum C, et al. Deficiency of brain 5-HT synthesis but serotonergic neuron formation in Tph2 knockout mice. J Neural Transm 2008;115:1127-32.
23. Hahn A, Ströhle A, Wolters M. Ernährung. 2. Aufl. Stuttgart: Wiss. Verl.-Ges., 2006.
24. Jackson DM. Beta-phenylethylamine and locomotor activity in mice. Interaction with catecholaminergic neurones and receptors. Arzneimittelforschung 1975;25:622-6.
25. Moja EA, Stoff DM, Gillin JC, Wyatt RJ. Dose-response effects of β-phenethylamine on stereotyped behaviour in pargyline-pretreated rats. Biol Psychiatr 1976;11:731-42.
26. Moja EA, Stoff DM, Gillin JC, Wyatt FJ. Neuroleptics attenuate stereotyped behaviour induced by β-phenethylamine in rats. Biol Psychiatr 1978;13:291-5.
27. Munro HN. Control of plasma amino acid concentrations. In: Ciba Foundation Symposium 22 (new series) (eds.). Aromatic Amino Acids in the Brain. Amsterdam, London, New York: Elsevier, 1974:5-24.
28. Parker G, Crawford J. Chocolate craving when depressed: a personality marker. Br J Psychiatry 2007;191:351-2.
29. Parker G, Parker I, Brotchie H. Mood state effects of chocolate. J Affect Disord 2006;92:149-59.
30. Pastore P, Favaro G, Badocco D, Tapparo A, et al. Determination of biogenic amines in chocolate by ion chromatographic separation and pulsed integrated amperometric detection with implemented wave-form at Au disposable electrode. J Chromatogr A 2005;1098:111-5.
31. Potkin SG, Karoum F, Chuang LW, Cannon-Spoor HE, et al. Phenylethylamine in paranoid chronic schizophrenia. Science 1979;206:159.
32. Randrup A, Munkvad I. Dopa and other naturally occurring substances as causes of stereotypy and rage in rats. Acta Psychiatr Scand 1966;42(Suppl 191):193-9.
33. Reynolds GP, Riederer P, Sandler M. 2-Phenylethylamine and amphetamine in human brain: effects of L-deprenyl in Parkinson's disease. Br Biochem Soc Trans 1978;7:143-5.
34. Riederer P. L-dopa competes with tyrosine and tryptophan for human brain uptake. Nutr Metab 1980;24:417-23.
35. Sabelli HC, Vazquez AJ, Flavin D. Behavioural and electrophysiological effects of phenylethanolamine and 2-phenylethylamine. Psychopharmacologia 1975;42:117-25.
36. Shimazu S, Miklya I. Pharmacological studies with endogenous enhancer substances: beta-phenylethylamine, tryptamine, and their synthetic derivatives. Prog Neuropsychopharmacol Biol Psychiatry 2004;28:421-7.
37. Sloviter RS, Connor JD, Drust EG. Serotonergic properties of β-phenethylamine in rats. Neuropharmacology 1980;19:1071-4.
38. Sotnikova TD, Budygin EA, Jones SR, Dykstra LA, et al. Dopamine transporter-dependent and -independent actions of trace amine beta-phenylethylamine. J Neurochem 2004;91:362-73.
39. Souci SW, Fachmann W, Kraut H. Die Zusammensetzung der Lebensmittel, Nährwert-Tabellen. 7. Aufl. Stuttgart: Wiss. Verl.-Ges., 2008.
40. Tomaso di E, Beltramo M, Piomelli D, Brain cannabinoids in chocolate. Nature 1996;382:677-8.
41. Wolz M, Kaminski A, Löhle M, Koch R, et al. Chocolate consumption is increased in Parkinson's disease: Results from a self-questionnaire study. (submitted).
42. Wurtman RJ, Wurtman JJ. Carbohydrates and depression. Sci Am 1989;260:68-75.
43. Xie Z, Miller GM. Beta-phenylethylamine alters monoamine transporter function via trace amine-associated receptor 1: implication for modulatory roles of trace amines in brain. J Pharmacol Exp Ther 2008;325:617-28.
44. Ziegleder G, Stojacic E, Stumpf B. Occurrence of beta-phenylethylamine and its derivatives in cocoa and cocoa products. Z Lebensm Unters Forsch 1992;195:235-8.